(Q37089403)

18 August 2017

1 reference

title

Niacin and vitamin B6 in mental functioning: a review of controlled trials in humans (English)

1 reference

18 August 2017

Niacin and vitamin B6 in mental functioning: A review of controlled trials in humans (English)

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90060-Y

4 December 2022

0 references

0 references

0 references

1 reference

1 reference

J. Kleijnen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1828703

4 December 2022

P. Knipschild

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1828703

4 December 2022

language of work or name

English

0 references

publication date

1 May 1991

1 reference

full work available at URL

18 August 2017

https://api.elsevier.com/content/article/PII:000632239190060Y?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90060-Y

https://api.elsevier.com/content/article/PII:000632239190060Y?httpAccept=text/plain

4 December 2022

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90060-Y

4 December 2022

published in

Biological Psychiatry

1 reference

18 August 2017

volume

29

1 reference

18 August 2017

issue

9

1 reference

18 August 2017

page(s)

931-941

1 reference

Behavioral effects of drug therapy on psychogeriatric inpatients. II. Multivitamin supplement

18 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90060-Y

Nicotinic Acid in the Prevention and Treatment of Methionine-Induced Exacerbation of Psychopathology in Schizophrenics

4 December 2022

2

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90060-Y

Nicotinic acid in the treatment of newly admitted schizophrenic patients: a placebo-controlled study

4 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90060-Y

Potentiation of therapeutic effects of nicotinic acid by pyridoxine in chronic schizophrenics

4 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90060-Y

The effects of nicotinic acid, nicotinamide, and placebo on the chronic schizophrenic

4 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90060-Y

Vitamin/mineral supplementation and intelligence

4 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90060-Y

Effect of vitamin and mineral supplementation on intelligence of a sample of schoolchildren

4 December 2022

12

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90060-Y

Thiamine and Alzheimer's disease. A pilot study

4 December 2022

14

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90060-Y

TREATMENT OF DOWN'S SYNDROME WITH THE "U" SERIES OF DRUGS

4 December 2022

17

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90060-Y

Thyroid and vitamin-mineral supplement fail to improve IQ of mentally retarded adults

4 December 2022

18

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90060-Y

Effect of megavitamin treatment on mental performance and plasma vitamin B6 concentrations in mentally retarded young adults.

4 December 2022

20

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90060-Y

Do nutrient supplements and dietary changes affect learning and emotional reactions of children with learning difficulties? A controlled series of 16 cases.

4 December 2022

23

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90060-Y

Effect of vitamin and mineral supplementation on verbal and non-verbal reasoning of schoolchildren

4 December 2022

24

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90060-Y

Nicotinamide in the treatment of schizophrenia

4 December 2022

25

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90060-Y

Vitamin/mineral supplements and intelligence of institutionalized mentally retarded adults

4 December 2022

28

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90060-Y

Vitamin-mineral supplement fails to improve IQ of mentally retarded young adults

4 December 2022

29

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90060-Y

Potential problems with the widespread use of niacin

4 December 2022

32

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90060-Y

An evaluation of niacinamide in the treatment of childhood schizophrenia

4 December 2022

33

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90060-Y

Effects of megavitamin therapy on children with attention deficit disorders

4 December 2022

35

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90060-Y

Treatment of schizophrenia with nicotinic acid and nicotinamide

4 December 2022

39

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90060-Y

The effects of nicotinic acid and xanthinol nicotinate on human memory in different categories of age. A double blind study

4 December 2022

43

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90060-Y

Vitamin B6, magnesium, and combined B6-Mg: therapeutic effects in childhood autism.

4 December 2022

45

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90060-Y

CAN CHILDREN'S INTELLIGENCE BE INCREASED BY VITAMIN AND MINERAL SUPPLEMENTS?

4 December 2022

50

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90060-Y

5-hydroxytryptophan and pyridoxine. Their effects in young children with Down's syndrome

4 December 2022

53

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90060-Y

Nicotinic acid as adjuvant therapy in newly admitted schizophrenic patients

4 December 2022

54

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90060-Y

The effect of high doses of vitamin B6 on autistic children: a double- blind crossover study

4 December 2022

55

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90060-Y

Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome

4 December 2022

56

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90060-Y

Nicotinic acid therapy in chronic schizophrenia.

4 December 2022

57

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90060-Y

Use of megadoses of vitamins with minerals in Down syndrome

4 December 2022

58

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90060-Y

Nicotinic acid and nicotinamide in the treatment of chronic schizophrenia

4 December 2022

59

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90060-Y

Niacin in the Long-Term Treatment of Schizophrenia

4 December 2022

61

1 reference

https://api.crossref.org/works/10.1016/0006-3223(91)90060-Y

4 December 2022

Identifiers

1 reference

18 August 2017

1 reference